464 studies found for:    "Uveal diseases"
Show Display Options
Rank Status Study
1 Unknown  Etanercept: Single Blind Control Study in Ocular Manifestations of Behcet's Disease
Conditions: Behcet Syndrome;   Uveal Disease
Intervention: Drug: Etanercept, Methotrexate, Prednisolone
2 Unknown  FR901228 in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma
Conditions: Intraocular Melanoma;   Melanoma (Skin)
Intervention: Drug: romidepsin
3 Completed
Has Results
Reduced Fluence Visudyne-Anti-VEGF-Dexamethasone In Combination for AMD Lesions (RADICAL)
Conditions: Choroidal Neovascularization;   Macular Degeneration
Interventions: Drug: verteporfin;   Drug: ranibizumab;   Drug: dexamethasone
4 Completed
Has Results
Low Dose Interferon Alpha Treatment for Oral Ulcers of Behcet's Disease
Conditions: Behcet Syndrome;   Behcet Disease;   Mucocutaneous Ulceration
Intervention: Biological: Veldona,
5 Completed Corneal Specular Microscopy in Infectious and Noninfectious Uveitis
Condition: Uveitis
Intervention: Device: noncontact specular microscopy
6 Completed A Clinical Trial of Infliximab for Uveitis
Condition: Uveitis
Intervention: Drug: Remicade (infliximab)
7 Recruiting Special Investigation in Patients With Intestinal Behcet's Disease (All Case Investigation)
Condition: Behcet's Disease
8 Completed Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study
Conditions: Uveitis;   Cancer;   Infection;   Mortality;   Immunosuppression
9 Completed Correlation of Gene Abnormalities and Clinical Manifestations of Aniridia
Condition: Aniridia
10 Completed Combretastatin A4 Phosphate in Patients With Neovascular Age-Related Macular Degeneration
Conditions: Combretastatin A4 Phosphate;   Age-related Macular Degeneration;   AMD;   CNV;   Choroidal Neovascularization
Interventions: Drug: Combretastatin A-4 phosphate;   Drug: Combretastatin A-4 Phosphate
11 Terminated
Has Results
Microplasmin Intravitreal Administration in Participants With Uveitic Macular Edema
Condition: Uveitis
Intervention: Drug: Microplasmin
12 Completed Observation on the Treg in the Uveitis Patients
Condition: Uveitis
13 Completed Neovascular Age Related Macular Degeneration (AMD), Periocular Corticosteroids, and Photodynamic Therapy (PDT)
Conditions: Choroidal Neovascularization;   Age-Related Macular Degeneration
Intervention: Drug: Periocular injection of triamcinolone acetonide 40mg
14 Completed Retisert and Cataract Surgery in Patients With Severe Uveitis
Conditions: Intermediate Uveitis;   Posterior Uveitis
Intervention: Device: Retisert (fluocinolone acetonide implant)
15 Unknown  Intravitreal Pegaptanib in Treatment of Choroidal Neovascularisation Secondary to Pathologic Myopia
Condition: Myopic Choroidal Neovascular Membrane
Intervention: Drug: Intravitreal Pegaptanib
16 Recruiting Randomized Study for Efficacy and Safety of Ranibizumab 0.5mg in Treat-extend and Monthly Regimens in Patients With nAMD
Conditions: Age-related Macular Degeneration;   Choroidal Neovascularization
Intervention: Drug: Ranibizumab 0.5mg
17 Unknown  Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization in Ocular Histoplasmosis Syndrome
Condition: Ocular Histoplasmosis Syndrome
Intervention: Drug: ranibizumab
18 Completed Dendritic Cell Vaccination During Lymphoid Reconstruction
Conditions: Intraocular Melanoma;   Melanoma (Skin)
Interventions: Biological: Autologous Dendritic Cells (DC);   Drug: Fludarabine;   Biological: Autologous Lymphocyte Infusion (ALI)
19 Unknown  Intravitreal Adalimumab in Refractory Diabetic Retinopathy, Choroidal Neovascularization or Uveitis: A Pilot Study
Conditions: Uveitis;   Diabetic Retinopathy;   Choroidal Neovascularization
Intervention: Drug: adalimumab
20 Completed Lucentis KAV Study
Condition: Age Related Macular Degeneration
Interventions: Drug: Ranibizumab;   Drug: Verteporfin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years